Services
Intro Statement
Market data in the Pharmaceutical Industry is arguably the most vital ingredient to plan and execute
activities; especially in an industry where prices and advertising are heavily regulated.
Data is not only important for strategic planning i.e. new launches but also for tactical execution measures i.e. growing market share, deciding on seasonal offers etc.
Data helps businesses monitor their sales performance, improve their sales force efficiency, create value
for prescribers, dispensers and patients and achieve challenging targets.
Healthcare & Pharma Advisory
AMS Pharma Consultations leverage over 100 years of combined industry experience, a strong presence in key MENA countries, and an in-depth understanding of local culture and market dynamics to provide comprehensive consultations to pharmaceutical companies operating in the region.
Our Consultations cover:
- Market Entry Strategy: our consultants help you develop a data-driven and effective market entry strategy that considers the specific needs, drivers, and regulatory environment of each market.
- Distribution Partner Search: We identify and connect you with the right distribution partners to ensure your products reach the right audience and achieve commercial success.
- Market Analysis: we provide comprehensive market analyses that cover current trends, new product launches, pricing, competitive landscape, portfolio analysis and more.
- Regulatory Support: We navigate the complex regulatory landscape of the MENA region, ensuring your products comply with all relevant regulations.
- Ongoing Insights: Our team of experts keeps you up-to-date on the latest trends, technologies, and market dynamics in the pharmaceutical industry. AMS insights cover new product launches, products in pipeline, breakthrough innovations, new drug approvals, changes in the regulatory environment, future outlook and more.
Contact AMS today to learn how our Healthcare and Pharma Consultations can help you achieve your business goals in the MENA region.
Custom Market Research
Whether your company’s objective is to gain in-depth information about the market conditions, its competitors, the new opportunities out there, or if you simply need feedback on your product’s performance from prescribers or users; AMS will design a fully customized market research study tailored to your exact needs.
Powered with our team’s hands-on experience, extensive coverage of the Iraqi Market and our Pharmaceutical Market focus; we have helped many organizations gain a competitive edge in their decision-making process based on research outcomes.
Our custom market research studies have helped our clients answer key questions related to:
- Price Optimization
- Brand Perception
- Distribution Channel Mapping
- Parallel Importation
- Key Stakeholders Mapping
These answers served in the strategic planning process at both the corporate and business unit levels.
Contact us for your next market research project
Patient Support Programs
Building on its established reputation as a leading provider of market data, research, and consulting services to the pharmaceutical industry in the MENA region, AMS is proud to announce the expansion of its services to include patient support and affordability programs in Jordan and Iraq. This strategic move underscores AMS’s unwavering commitment to supporting the entire pharmaceutical ecosystem, not just pharmaceutical companies but also the patients who rely on their life-saving medications.
Understanding the Challenges:
Accessibility and affordability of medication remain major challenges in Jordan and Iraq. Complexities in healthcare systems, coupled with economic constraints, often prevent patients from accessing the critical treatments they need. This not only has a detrimental impact on patient health outcomes but also poses significant hurdles for pharmaceutical companies seeking to reach their target patients.
AMS to Bridge the Gap:
Through its newly established patient support and affordability programs, AMS aims to bridge this gap and address these critical challenges. By leveraging its extensive experience and expertise in the MENA region, AMS will develop and implement customized solutions that will improve patients’ access to essential medications.
- Co-pay assistance programs, patient education initiatives, and collaboration with healthcare providers to streamline access pathways.
- Improve affordability.
- Enhance patient engagement and adherence: By providing educational resources and building trust with patients, AMS will encourage medication adherence and improve treatment outcomes.
Collaboration for a Greater Impact:
AMS recognizes that collaboration is key to achieving its goals. The company will work closely with pharmaceutical companies, healthcare providers, patient advocacy groups, and government agencies to develop and implement effective and sustainable patient support and affordability programs.
This expansion marks a significant milestone in AMS’s journey to becoming a one-stop shop for pharmaceutical companies operating in the MENA region. By addressing both market intelligence and patient-centric needs, AMS is committed to driving positive change and improving the health and well-being of patients across the region.
Pharmaceutical Sales Monitors
AMS’s core competence is providing our clients with a tool that allows them to make sense of diverse, uncertain and complex high-volume markets.
We achieve this by working very diligently at acquiring data through:
- Randomized scientific sampling.
• Projections based on statistically proven formulas.
• Application of Stringent Data Validation methods.
• Continuous update and assessment of our methodology.
AMS issues quarterly sales monitors for the pharmaceutical markets in:
• Iraq since 2010
• Syria since 2000
• Sudan since 2007
• Kurdistan region since 2012
- Jordan since 2021
• Libya from 2007- 2018 and re-entry in 2023
(Each links to the related data in the statistics page)
AMS Sales Monitors are provided in the form of easy-to use proprietary software (PharmView) and are designed to accurately reflect the quantitative sales of pharmaceutical products in the private sector and show ranking of performance by both unit and value (US$ and local currency) in terms of:
Manufacturers, Products, Product form, ATC1-ATC4 Classification, % of Total Market Share, % of the Selected Market Share, Growth and Evolution.
The software application PharmView can provide data in various shapes and forms thus ensuring it meets our client’s needs. (Link to PharmView Video)
Talk to our Sales Team for more information
Institutional (Tender) Studies
In addition to its comprehensive private market sales monitors, AMS offers a unique service: Institutional (Tender) Studies. These quarterly reports provide businesses with an in-depth analysis of public procurement activities within the pharmaceutical industry. This service complements AMS’ existing offerings and delivers an unparalleled holistic view of both private and public market dynamics.
AMS meticulously analyzes all tenders awarded by and delivered to the Iraqi Ministry of Health (KIMADIA), ensuring an accurate and reliable display of data. By understanding government priorities and purchasing patterns, businesses can identify potential opportunities and niche markets within the public sector.
Institutional data offers valuable insights not only for pharmaceutical manufacturers and distributors, but also to healthcare investors, analysts, and market research agencies.
By combining private and public data, businesses gain a comprehensive understanding of the entire pharmaceutical market landscape in Iraq.
Currently, AMS Institutional Studies are available for the Iraqi pharmaceutical market. However, AMS is actively expanding its reach and will soon offer an institutional study for the Jordanian market.
Talk to our Sales Team for more information
Medical Prescriptions Monitors
The Medical Prescriptions Monitor is a quarterly study published by AMS in the Jordanian market with the purpose of providing Pharmaceutical Companies with a qualitative tool to measure the performance of their own Medical Representatives and that of their competitors. It is a very important measure of the promotional message reaching the doctors as well.
Data is provided by top Medical Insurance Companies in Jordan and processed by an advanced program to map the patient’s journey from visiting a physician, to diagnosis, prescription, revisits, brand substitution…etc.
The data can be displayed by Physician Specialty, by Diagnosis, by Therapeutic Class and by Product.
New features will be available for users as of Quarter 4/ 2023, including the New/ Repeat/ Change feature, providing detailed analysis of prescriptions, and translating data into valuable insights into physicians’ behavior and brand loyalty.
Medical Prescriptions Monitor will soon be available for the Iraqi Market.
Talk to our Sales Team for more information.